Navigation Links
New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy

COLLEGEVILLE, Pa., April 03, 2007 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , provides comment on a re- analysis of pooled data from both hormone therapy arms of the Women's Health Initiative (WHI) Study published today in the Journal of the American Medical Association. The pooled analysis showed no apparent increase in coronary heart disease for women who initiate hormone therapy close to menopause.

The publication also reports a statistically nonsignificant trend toward a reduction in coronary heart disease among hormone therapy users within 10 years of menopause. Study authors also reported a statistically significant reduction in total mortality among women aged 50-59 in the group receiving hormone therapy compared with those in the placebo group with a nonsignificant trend for increasing risk across other age groups. Additionally, consistent with previous findings, an increase in the risk of stroke for women taking hormone therapy was confirmed in this pooled analysis.

"These pooled findings with respect to coronary heart disease may be reassuring to newly menopausal women," says Joseph Camardo, M.D., Senior Vice President of Global Medical Affairs for Wyeth Pharmaceuticals. "Hormone therapy remains a good health care choice for the appropriate woman seeking the relief of moderate to severe menopausal symptoms, including hot flashes, night sweats and vaginal atrophy and the prevention of postmenopausal osteoporosis. Hormone therapy should not be used for the prevention of cardiovascular disease.

"Furthermore, the overall findings of this pooled analysis of the WHI are consistent with major observational studies, such as the Nurses' Health Study," adds Dr. Camardo. "The overall risk/benefit ratio with hormone therapy may depend on many factors, including the type of therapy a woman chooses, such as estrogen or estrogen plus progestin, as well as a woman's age
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
4. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
5. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
6. Haemacure Announces Preliminary Findings of its Plasma Discard Analysis
7. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
10. Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
11. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
Post Your Comments:
(Date:7/30/2015)... N.J. , July 30, 2015  Unichem Pharmaceuticals ... recalling one lot of Hydrochlorothiazide tablets 25 mg 1000-count ... initiated as a precautionary measure due to the identification ... the product. The risk associated with ... tablet is the increased probability of experiencing Clopidogrel,s side ...
(Date:7/30/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced the ... of Warburg Pincus LLC, to the Amgen Board of Directors. ... Hassan and the deep, global experience he brings in ... A. Bradway , chairman and chief executive officer of Amgen. "Fred,s ... Amgen well." Mr. Hassan has been Partner and ...
(Date:7/30/2015)... -- Growth of the U.S. nonprescription market is primarily driven ... to the OTC market. Due to an increasingly favorable ... activity over the next five years with several all ... entering the market into existing categories. If ... those with low to moderate likelihood), the market is ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... announces that a new market research report ... IP Overview – "Monoclonal Antibodies ... http://www.reportlinker.com/p0296354/IP-Overview-–-"Monoclonal-Antibodies-against-digestive-system-cancers"-Patent-Landscape-2010.html ... digestive system cancers, monoclonal antibody-based therapies have ...
... MORRISVILLE, N.C., Sept. 21 During the recent ... the European Association of Cardiac Thoracic Surgeons in ... Surgery from University Medical Center in Ljubljana, Slovenia ... professionals to think differently about existing atrial fibrillation ...
Cached Medicine Technology:Reportlinker Adds IP Overview - "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010 2Reportlinker Adds IP Overview - "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010 3Interdisciplinary Convergent Approach May Represent Future for Treatment of Atrial Fibrillation 2Interdisciplinary Convergent Approach May Represent Future for Treatment of Atrial Fibrillation 3
(Date:7/31/2015)... , ... July 31, 2015 , ... Ticket Down is ... Those looking to catch a new and refreshing show on Broadway, look no ... and achievements including an Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... and potential patients alike on various plastic surgery procedures including, but not limited ... such popular dermatology procedures like Botox and fillers. , Staying up to ...
(Date:7/31/2015)... ... July 31, 2015 , ... “Engage: ... of the industry’s premier thought leadership symposiums, hosted by Massachusetts-based Harmony Healthcare ... The event attracts over 250 “C”-level executives, administrators, directors of nursing, rehabilitation managers ...
(Date:7/31/2015)... ... July 31, 2015 , ... BioViva USA, Inc. (“BioViva”), ... we treat aging diseases. , BioViva announces it has begun a fundraiser through ... Alzheimer’s Disease (AD) and find a cure. MaxLife will grant 100% of the money ...
(Date:7/31/2015)... ... 31, 2015 , ... The alarm was ringing. Hugh Chatfield, survivor of a severe 1987 brain ... recalled that his equipment was set up to depict the newly poured concrete. With a ... , The photo speaks for itself. Chatfield is also a highly praised safety and drug ...
Breaking Medicine News(10 mins):Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3
... Longstanding CDH Relationship Remains Collaborative , ... , , ... ... WHEATON, Ill. , March 17 Life Care Services LLC (LCS) of ...
... financial rating tools are reliable , WEDNESDAY, March 17 ... reduce U.S. health-care costs, a new study suggests. , ... to encourage patients to receive care from doctors who ... these efforts may not be based on reliable estimates ...
... ... clinical trials , ... (Vocus) March 17, 2010 -- Guy Lee, M.D. , spine surgeon at Abington Memorial ... spinal stenosis using the Superion™ Interspinous Spacer (ISS) from VertiFlex® Inc., , ,The ...
... ... , ... ... BOISE, Idaho , March 17 Idahoans may soon learn someone else,s "conscience" at the worst possible time. ...
... deadly infections long has focused on looking for ways to ... of Utah and Utah State University shows that modulating the ... more lives. In a study published March 17 ... of U cardiologist Dean Y. Li, M.D., Ph.D., professor of ...
... The Community Oncology Alliance (COA) today announced the ... Selma, Alabama . That brings a total of at least ... --with the majority increasing from 2009 forward -- due to ... care. Yet the current healthcare reform plans do not address ...
Cached Medicine News:Health News:Wyndemere Senior Living Community Acquired by Life Care Services 2Health News:Wyndemere Senior Living Community Acquired by Life Care Services 3Health News:Wyndemere Senior Living Community Acquired by Life Care Services 4Health News:Ranking Doctors by Cost-Profile May Not Help Save Money 2Health News:Abington Surgeon First in Pennsylvania to Implant Investigative Device to Treat Leg Pain Caused by Spinal Stenosis 2Health News:Abington Surgeon First in Pennsylvania to Implant Investigative Device to Treat Leg Pain Caused by Spinal Stenosis 3Health News:Abington Surgeon First in Pennsylvania to Implant Investigative Device to Treat Leg Pain Caused by Spinal Stenosis 4Health News:Idaho Passes Bill to Put 'Conscience' Between Patients & End of Life Rights 2Health News:Idaho Passes Bill to Put 'Conscience' Between Patients & End of Life Rights 3Health News:Targeting blood vessels, immune system may offer way to stop infection-caused inflammation 2Health News:Targeting blood vessels, immune system may offer way to stop infection-caused inflammation 3Health News:Latest Cancer Clinic Closure in Selma, Alabama 2Health News:Latest Cancer Clinic Closure in Selma, Alabama 3Health News:Latest Cancer Clinic Closure in Selma, Alabama 4
... The Research Family includes fixed-volume, adjustable-volume, ... the electronic Eppendorf Research pro Pipette. ... these compact, high-performance pipettes have earned ... suited for use with original Eppendorf ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... is ideal for repeated pipetting ... volume FInnpipettes offer the same ... Finnpipette Digital pipettes: New, ... Soft-touch tip ejection, Safety label, ...
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Medicine Products: